Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Last week, our lecturers attended two training days at our head office, at Stroke Association House, London. These form part of a schedule of activity designed to ensure they have the skills, and support needed to succeed in becoming the next generation of research leaders.
Watch the highlights summary video from the ISC Programme Committee, and find out about the result of the international HeadPoST trial, and take-homes from our International Development Officer, Sarah Belson.
The Medical Research Council launched a £5m call for capital investment to support between two to five human tissue banks with linked data resources.
Funded by the European Union (EU), a new international study called PROOF will investigate whether high-dose oxygen therapy can reduce the effects of stroke.
The Stroke Association is a member of the Stroke Alliance For Europe (SAFE), which will work on communication of information about the PROOF trial to non-clinical audiences.
To help plan the care of stroke survivors and their rehabilitation, health professionals usually use a scale called the Barthel Index (BI) to measure how well they can perform activities of daily living (ADLs).
UK Stroke Forum 2016 took place from Monday to Wednesday (28-30 November) at the ACC in Liverpool. UK Stroke Forum is the largest multidisciplinary stroke event in the UK, attracting over 1400 delegates from across the stroke care pathway. The event showcases what's hot in the UK stroke community, including the latest research, and how stroke professionals can get involved in research.
This study is investigating how to make thoracic endovascular aortic stenting (TEVAR), treatment for thoracic aortic disease (TAD), safer by using extra protection devices.